老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Addex Therapeutics Ltd

3.04
-0.1786-5.55%
盘前：2.98-0.0600-1.97%07:36 EDT
成交量：2,671
成交额：8,339.81
市值：532.74万
市盈率：-0.35
高：3.20
开：3.08
低：2.97
收：3.22
52周最高：11.97
52周最低：2.56
股本：175.24万
流通股本：156.70万
量比：0.40
换手率：0.17%
股息：- -
股息率：- -
每股收益(TTM):-8.6640
每股收益(LYR):-9.4830
净资产收益率：-150.58%
总资产收益率：-27.12%
市净率：2.32
市盈率(LYR):-0.32

数据加载中...

总览公司新闻资讯公告
2021/09/08

超过5%披露

Addex Therapeutics Ltd.
2021/04/12

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/08

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/01/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/06

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/05

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/14

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/11/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/04/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

SEC问询函

[Cover]Correspondence
2020/01/23

SEC问询函

[Cover]Correspondence
2020/01/23

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
更多